Sunshine Biopharma (SBFM) Debt to Equity (2017 - 2021)
Sunshine Biopharma (SBFM) reported Debt to Equity of $8.98 for Q4 2021, up 1003.17% on a YoY basis from $0.81 in Q4 2020, and up 428.88% quarter-over-quarter from -$2.73 in Q3 2021.
Sunshine Biopharma (SBFM) Debt to Equity (2017 - 2021) Analysis & Trends
Sunshine Biopharma has reported Debt to Equity for 5 years, with the latest figure at $8.98 in Q4 2021.
- For the quarter ending Q4 2021, Debt to Equity rose 1003.17% year-over-year to $8.98; the trailing twelve-month figure through Dec 2021 stood at $8.98 (up 1003.17% YoY), and the FY2021 full-year result was $8.98, up 1003.17% from the prior year.
- Debt to Equity for Q4 2021 stood at $8.98, up from -$2.73 in the prior quarter.
- The five-year high for Debt to Equity was $8.98 in Q4 2021, with the low at -$5.57 in Q4 2018.
- Historically, Debt to Equity has averaged -$0.64 across 5 years, with a median of -$0.99 in 2020.
- Annual changes were most pronounced in 2018 — Debt to Equity tumbled 3908.81% — and 2021, when it soared 1003.17%.
- Sunshine Biopharma's Debt to Equity stood at -$0.14 in 2017, then tumbled by 3908.81% to -$5.57 in 2018, then surged by 99.33% to -$0.04 in 2019, then sank by 2580.8% to -$0.99 in 2020, then surged by 1003.17% to $8.98 in 2021.
- The last three Debt to Equity figures came in at $8.98 (Q4 2021), -$2.73 (Q3 2021), and -$2.35 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.02 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.80 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.01 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.61 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 0.86 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 0.47 |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 8.98 |
| Sep 30, 2021 | -2.73 |
| Jun 30, 2021 | -2.35 |
| Mar 31, 2021 | -1.92 |
| Dec 31, 2020 | -0.99 |
| Sep 30, 2020 | -0.64 |
| Jun 30, 2020 | -0.11 |
| Sep 30, 2019 | -0.04 |
| Jun 30, 2019 | -0.03 |
| Mar 31, 2019 | -1.65 |
| Dec 31, 2018 | -5.57 |
| Jun 30, 2018 | -1.12 |
| Dec 31, 2017 | -0.14 |